Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models

por Hu, Jinsong, Van Valckenborgh, Els, Menu, Eline, De Bruyne, Elke, Vanderkerken, Karin
Publicado 2012

Novel strategies to target the ubiquitin proteasome system in multiple myeloma

por Lub, Susanne, Maes, Ken, Menu, Eline, De Bruyne, Elke, Vanderkerken, Karin, Van Valckenborgh, Els
Publicado 2015

Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy

por Dufait, Inès, Van Valckenborgh, Els, Menu, Eline, Escors, David, De Ridder, Mark, Breckpot, Karine
Publicado 2016

Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma

por Maes, Ken, Menu, Eline, Van Valckenborgh, Els, Van Riet, Ivan, Vanderkerken, Karin, De Bruyne, Elke
Publicado 2013

The Effects of Forodesine in Murine and Human Multiple Myeloma Cells

por Bieghs, Liesbeth, Caers, Jo, De Bruyne, Elke, Van Valckenborgh, Els, Higginbotham, Fiona, Vanderkerken, Karin, Menu, Eline
Publicado 2010

Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma

por Wang, Jinheng, Faict, Sylvia, Maes, Ken, De Bruyne, Elke, Van Valckenborgh, Els, Schots, Rik, Vanderkerken, Karin, Menu, Eline
Publicado 2016

The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells

por Wang, Jinheng, De Veirman, Kim, De Beule, Nathan, Maes, Ken, De Bruyne, Elke, Van Valckenborgh, Els, Vanderkerken, Karin, Menu, Eline
Publicado 2015

Increased resistance to proteasome inhibitors in multiple myeloma mediated by cIAP2 - implications for a combinatorial treatment

por Duvefelt, Charlotte Fristedt, Lub, Susanne, Agarwal, Prasoon, Arngården, Linda, Hammarberg, Anna, Maes, Ken, Van Valckenborgh, Els, Vanderkerken, Karin, Wiklund, Helena Jernberg
Publicado 2015

The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma

por Maes, Ken, Smedt, Eva De, Lemaire, Miguel, Raeve, Hendrik De, Menu, Eline, Van Valckenborgh, Els, McClue, Steve, Vanderkerken, Karin, De Bruyne, Elke
Publicado 2014

Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies

por De Veirman, Kim, Van Valckenborgh, Els, Lahmar, Qods, Geeraerts, Xenia, De Bruyne, Elke, Menu, Eline, Van Riet, Ivan, Vanderkerken, Karin, Van Ginderachter, Jo A.
Publicado 2014

The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential

por Bieghs, Liesbeth, Johnsen, Hans E., Maes, Ken, Menu, Eline, Van Valckenborgh, Els, Overgaard, Michael T., Nyegaard, Mette, Conover, Cheryl A., Vanderkerken, Karin, De Bruyne, Elke
Publicado 2016

In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma

por Maes, Ken, De Smedt, Eva, Kassambara, Alboukadel, Hose, Dirk, Seckinger, Anja, Van Valckenborgh, Els, Menu, Eline, Klein, Bernard, Vanderkerken, Karin, Moreaux, Jérôme, De Bruyne, Elke
Publicado 2014

Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma

por De Veirman, Kim, Rao, Luigia, De Bruyne, Elke, Menu, Eline, Van Valckenborgh, Els, Van Riet, Ivan, Frassanito, Maria Antonia, Di Marzo, Lucia, Vacca, Angelo, Vanderkerken, Karin
Publicado 2014

Roadbook for the implementation of next-generation sequencing in clinical practice in oncology and hemato-oncology in Belgium

por Van Valckenborgh, Els, Hébrant, Aline, Antoniou, Aline, Van Hoof, Wannes, Van Bussel, Johan, Pauwels, Patrick, Salgado, Roberto, Van Doren, Waltruda, Waeytens, Anouk, Van den Bulcke, Marc
Publicado 2018

Standardization of Somatic Variant Classifications in Solid and Haematological Tumours by a Two-Level Approach of Biological and Clinical Classes: An Initiative of the Belgian ComP...

por Froyen, Guy, Le Mercier, Marie, Lierman, Els, Vandepoele, Karl, Nollet, Friedel, Boone, Elke, Van der Meulen, Joni, Jacobs, Koen, Lambin, Suzan, Vander Borght, Sara, Van Valckenborgh, Els, Antoniou, Aline, Hébrant, Aline
Publicado 2019

Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells

por Lub, Susanne, Maes, Anke, Maes, Ken, De Veirman, Kim, De Bruyne, Elke, Menu, Eline, Fostier, Karel, Kassambara, Alboukadel, Moreaux, Jérôme, Hose, Dirk, Leleu, Xavier, King, Randall W., Vanderkerken, Karin, Van Valckenborgh, Els
Publicado 2015

The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic

por Bieghs, Liesbeth, Lub, Susanne, Fostier, Karel, Maes, Ken, Van Valckenborgh, Els, Menu, Eline, Johnsen, Hans E., Overgaard, Michael T., Larsson, Olle, Axelson, Magnus, Nyegaard, Mette, Schots, Rik, Jernberg-Wiklund, Helena, Vanderkerken, Karin, De Bruyne, Elke
Publicado 2014

Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells

por De Veirman, Kim, Van Ginderachter, Jo A., Lub, Susanne, De Beule, Nathan, Thielemans, Kris, Bautmans, Ivan, Oyajobi, Babatunde O., De Bruyne, Elke, Menu, Eline, Lemaire, Miguel, Van Riet, Ivan, Vanderkerken, Karin, Van Valckenborgh, Els
Publicado 2015

NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program

por Delcourt, Thomas, Vanneste, Kevin, Soumali, Mohamed Rida, Coucke, Wim, Ghislain, Vanessa, Hebrant, Aline, Van Valckenborgh, Els, De Keersmaecker, Sigrid C. J., Roosens, Nancy H., Van De Walle, Philippe, Van Den Bulcke, Marc, Antoniou, Aline
Publicado 2020

Preclinical Evaluation of Invariant Natural Killer T Cells in the 5T33 Multiple Myeloma Model

por Nur, Haneen, Fostier, Karel, Aspeslagh, Sandrine, Renmans, Wim, Bertrand, Elisabeth, Leleu, Xavier, Favreau, Mérédis, Breckpot, Karine, Schots, Rik, De Waele, Marc, Van Valckenborgh, Els, De Bruyne, Elke, Facon, Thierry, Elewaut, Dirk, Vanderkerken, Karin, Menu, Eline
Publicado 2013